Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
153.1 USD | -0.71% |
|
-3.07% | +58.78% |
Jun. 26 | Monetary policy is getting even more confusing | ![]() |
Jun. 26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.78% | 14.47B | |
+15.58% | 121B | |
+16.60% | 110B | |
+18.52% | 25.98B | |
-24.33% | 19.27B | |
-18.35% | 15.99B | |
-17.95% | 15.66B | |
-48.32% | 14.5B | |
+4.91% | 13.91B | |
+100.06% | 10B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- RBC Raises Price Target on Sarepta Therapeutics to $182 From $142, Maintains Sector Perform Rating